Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis

Table 3 Comparison of patients with cryptogenic cirrhosis and disease controls separated by the etiology of cirrhosis

Variable	Cryptogenic (n =134, %)	CHC (n = 81, %)	Alcohol (n = 33, %)	AIH (n = 20, %)	P
Sex (female)	83 (62)	54 (66.7)	7 (21.2)	14 (70)	< 0.001
DM	53 (40)	17 (21)	10 (30.3)	3 (15)	0.013
HBP	24 (18)	8 (10)	4 (12.1)	2 (10)	0.36
Hyperuricemia	13 (10)	1 (1.2)	0 (0)	1 (5)	0.027
Dyslipidemia	72 (54)	5 (6)	1 (3)	2 (10)	< 0.001
Overweight (BMI > 25)	103 (77)	63 (78)	27 (81.8)	16 (80)	0.93
Obesity (BMI > 30)	22 (16.4)	5 (6.2)	5 (15.2)	1 (5)	0.10
MS	39 (29.1)	5 (6.2)	2 (6)	1 (5)	< 0.001
Age (yr, mean ± SD)	54.6 ± 14.3	56.8 ± 11.4	58 ± 12.6	55.6 ± 14.1	0.48
BMI (mean ± SD)	27 ± 4.6	26 ± 4	26.4 ± 3.5	26.1 ± 5.1	0.65
ALT (U/L, mean ± SD)	52.5 ± 59	57.5 ± 33	52.6 ± 47.9	46.2 ± 27.7	0.79
AST (U/L, mean ± SD)	67.1 ± 60	77.8 ± 46	73.1 ± 52	73.5 ± 69	0.59

CHC: Cirrhosis by hepatitis C virus; AIH: Autoimmune hepatitis; DM: Diabetes mellitus; HBP: High blood pressure; BMI: Body mass index (calculated as patients’ body weight divided by the square of the height expressed in kg/m²); MS: Metabolic syndrome.